Latest News  

Dietary Calcium Intake Not Associated with Bone Loss

Postmenopausal women are often told to consume more than 1,500 mg of calcium daily to reach neutral bone balance. But new research suggests this recommendation should be revised, finding no connection between dietary calcium intake and postmenopausal bone loss… [Read More]

Mirikizumab Promising for Plaque Psoriasis

During a 16-week study, patients with plaque psoriasis taking mirikizumab experienced higher response rates and skin clearance compared with placebo… [Read More]

Osteoporotic Fracture Rates Similar with Denosumab, Alendronate in Real World

NEW YORK (Reuters Health)—Rates of osteoporotic fracture were similar three years after starting either denosumab or alendronate in a real-world Danish population-based cohort study. “Previous… [Read More]

For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety

NEW YORK (Reuters Health)—In patients with psoriasis and psoriatic arthritis, the incidence of atrial fibrillation and major adverse cardiovascular events does not differ between treatment… [Read More]

Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis

Japan has approved risankizumab for treating plaque psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adults… [Read More]

FDA Greenlights Osteoporosis Drug for Postmenopausal Women

(Reuters)—The U.S. Food and Drug Administration says it has approved Amgen’s osteoporosis treatment for postmenopausal women who are at high risk of fracture. Evenity (romosozumab-aqqg),… [Read More]

View More Latest News »